Literature DB >> 24593153

Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival.

Wareed Ahmed1, Shruti Menon, Adwait Anand Godbole, Pullela V D N B Karthik, Valakunja Nagaraja.   

Abstract

Topoisomerases are an important class of enzymes for regulating the DNA transaction processes. Mycobacterium tuberculosis (Mtb) is one of the most formidable pathogens also posing serious challenges for therapeutic interventions. The organism contains only one type IA topoisomerase (Rv3646c), offering an opportunity to test its potential as a candidate drug target. To validate the essentiality of M. tuberculosis topoisomerase I (TopoI(Mt) ) for bacterial growth and survival, we have generated a conditionally regulated strain of topoI in Mtb. The conditional knockdown mutant exhibited delayed growth on agar plate. In liquid culture, the growth was drastically impaired when TopoI expression was suppressed. Additionally, novobiocin and isoniazid showed enhanced inhibitory potential against the conditional mutant. Analysis of the nucleoid revealed its altered architecture upon TopoI depletion. These studies establish the essentiality of TopoI for the M. tuberculosis growth and open up new avenues for targeting the enzyme.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Mycobacterium tuberculosis; cell growth; conditional silencing; essential genes; topoisomerase I

Mesh:

Substances:

Year:  2014        PMID: 24593153     DOI: 10.1111/1574-6968.12412

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  28 in total

Review 1.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Distinct Mechanism Evolved for Mycobacterial RNA Polymerase and Topoisomerase I Protein-Protein Interaction.

Authors:  Srikanth Banda; Nan Cao; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2017-08-24       Impact factor: 5.469

3.  Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors.

Authors:  Adwait Anand Godbole; Wareed Ahmed; Rajeshwari Subray Bhat; Erin K Bradley; Sean Ekins; Valakunja Nagaraja
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

4.  Insights from the Structure of Mycobacterium tuberculosis Topoisomerase I with a Novel Protein Fold.

Authors:  Kemin Tan; Nan Cao; Bokun Cheng; Andrzej Joachimiak; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2015-12-03       Impact factor: 5.469

5.  Synthesis, evaluation, and CoMFA study of fluoroquinophenoxazine derivatives as bacterial topoisomerase IA inhibitors.

Authors:  Xufen Yu; Mingming Zhang; Thirunavukkarasu Annamalai; Priyanka Bansod; Gagandeep Narula; Yuk-Ching Tse-Dinh; Dianqing Sun
Journal:  Eur J Med Chem       Date:  2016-09-18       Impact factor: 6.514

6.  Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.

Authors:  Rashmi Gupta; Carolina Rodrigues Felix; Matthew P Akerman; Kate J Akerman; Cathryn A Slabber; Wenjie Wang; Jessie Adams; Lindsey N Shaw; Yuk-Ching Tse-Dinh; Orde Q Munro; Kyle H Rohde
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

7.  Antimicrobial Susceptibility and SOS-Dependent Increase in Mutation Frequency Are Impacted by Escherichia coli Topoisomerase I C-Terminal Point Mutation.

Authors:  Jenny Yang; Thirunavukkarasu Annamalai; Bokun Cheng; Srikanth Banda; Rakhi Tyagi; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

8.  Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.

Authors:  Purushottam B Tiwari; Prem P Chapagain; Ahmed Seddek; Thirunavukkarasu Annamalai; Aykut Üren; Yuk-Ching Tse-Dinh
Journal:  ChemMedChem       Date:  2020-03-18       Impact factor: 3.466

9.  A simplified protocol for high-yield expression and purification of bacterial topoisomerase I.

Authors:  Jesse A Jones; Emily Price; Donovan Miller; Kirk E Hevener
Journal:  Protein Expr Purif       Date:  2016-04-23       Impact factor: 1.650

10.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.